Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic Rats.

Al-Malki AL.

Evid Based Complement Alternat Med. 2013;2013:983923. doi: 10.1155/2013/983923. Epub 2013 Jan 10.

2.

Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.

Kowluru RA, Koppolu P, Chakrabarti S, Chen S.

Free Radic Res. 2003 Nov;37(11):1169-80.

PMID:
14703729
3.

Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B.

Schiekofer S, Rudofsky G Jr, Andrassy M, Schneider J, Chen J, Isermann B, Kanitz M, Elsenhans S, Heinle H, Balletshofer B, Häring HU, Schleicher E, Nawroth PP, Bierhaus A.

Diabetes Obes Metab. 2003 Jul;5(4):251-61.

PMID:
12795658
5.

Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.

Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, Vom Hagen F, Nawroth P, Brownlee M, Hammes HP.

Diabetologia. 2006 May;49(5):1089-96. Epub 2006 Mar 7.

PMID:
16520919
6.

Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.

Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4898-904. doi: 10.1167/iovs.08-2013. Epub 2009 Jun 24.

PMID:
19553613
7.

Attenuation of aortic injury by ursolic acid through RAGE-Nox-NFκB pathway in streptozocin-induced diabetic rats.

Xiang M, Wang J, Zhang Y, Ling J, Xu X.

Arch Pharm Res. 2012 May;35(5):877-86. doi: 10.1007/s12272-012-0513-0. Epub 2012 May 29.

PMID:
22644855
8.
9.

Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.

Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ.

Diabetes. 2003 Mar;52(3):864-71.

11.

Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells.

Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R.

Diabetes. 1999 Apr;48(4):855-64.

PMID:
10102704
13.

Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.

Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4342-50.

PMID:
17724226
14.

Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades.

Negi G, Kumar A, Sharma SS.

J Pineal Res. 2011 Mar;50(2):124-31. doi: 10.1111/j.1600-079X.2010.00821.x. Epub 2010 Nov 9.

PMID:
21062351
15.

Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats.

Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, Frank RN, Stevens MJ.

Diabetologia. 2001 Sep;44(9):1102-10.

16.

[Inhibitory effects of reduced glutathione sodium on renal nuclear factor-kappaB expression in rats with diabetes of different stages].

Wang YT, Wang J, Zhao M, DI HJ.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):332-5. Chinese.

17.

Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.

Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS.

Diabetes. 2007 Feb;56(2):337-45. Erratum in: Diabetes. 2007 May;56(5):1486.

18.

Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress.

Yülek F, Or M, Ozoğul C, Isik AC, Ari N, Stefek M, Bauer V, Karasu C.

Arch Med Res. 2007 Jul;38(5):503-11.

PMID:
17560455
19.

Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy.

Shelton MD, Kern TS, Mieyal JJ.

J Biol Chem. 2007 Apr 27;282(17):12467-74. Epub 2007 Feb 26.

20.

Hypoxia and oxidative stress in the causation of diabetic retinopathy.

Arden GB, Sivaprasad S.

Curr Diabetes Rev. 2011 Sep;7(5):291-304. Review.

PMID:
21916837

Supplemental Content

Support Center